| Glaxosmithkline Share Price | |||
|---|---|---|---|
| Price | 1,938.00 | Open | 1,915.50 |
| Bid | 1,938.50 | High | 1,940.00 |
| Ask | 1,939.50 | Low | 1,908.00 |
| Change | 36.00 (1.89%) | Close | 1,902.00 |
| Volume | 6,350,731 | ||
| Currency | GBX |
|---|---|
| Issue Country | GB |
| Shares in Issue | 4.01b |
| Market Cap | £77.72b |
| PE Ratio | 13.73494 |
| EPS | 141.10 |
| Year High | 2,282.00 |
|---|---|
| Year High Date | 18-Feb-2026 |
| Year Low | 1,315.00 |
| Year Low Date | 18-Jul-2025 |
| Dividend | 63.00 |
| Yield | 3.251% |
| # Trades | 9,036 |
|---|---|
| Vol. Sold | 1,121,859 |
| Sold Value | £21.49m |
| Vol. Bought | 4,328,990 |
| Bought Value | £83.75m |
| Market Size | 1,000 |
| Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
|---|---|---|---|---|---|---|---|---|
| 05-Jun-26 | 16:24:47 | 1,936.00 | 52 | Unknown* | 1,938.50 | 1,939.50 | 1,007 | O Ordinary Delayed publication Was reported as OTC |
| 05-Jun-26 | 16:16:15 | 1,937.00 | 0 | Unknown* | 1,938.50 | 1,939.50 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
| 05-Jun-26 | 16:16:16 | 1,937.00 | 0 | Unknown* | 1,938.50 | 1,939.50 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
| 05-Jun-26 | 16:16:16 | 1,937.00 | 0 | Unknown* | 1,938.50 | 1,939.50 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
| 05-Jun-26 | 16:16:15 | 1,937.00 | 0 | Unknown* | 1,938.50 | 1,939.50 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
| 05-Jun-26 | 16:16:15 | 1,937.00 | 0 | Unknown* | 1,938.50 | 1,939.50 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
| 05-Jun-26 | 16:16:15 | 1,937.00 | 0 | Unknown* | 1,938.50 | 1,939.50 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
| 05-Jun-26 | 16:28:58 | 1,939.00 | 0 | Unknown* | 1,938.50 | 1,939.50 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
| 05-Jun-26 | 16:22:48 | 1,936.50 | 0 | Unknown* | 1,938.50 | 1,939.50 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
| 05-Jun-26 | 16:22:48 | 1,936.50 | 0 | Unknown* | 1,938.50 | 1,939.50 | 0.00 | O Ordinary Delayed publication Was reported as OTC |
| Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
|---|---|---|---|---|---|---|---|
| 20-May-26 | 15-May-26 | Buy | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 49.67 | USD | 74 | 15,323,778 |
| 19-May-26 | 15-May-26 | Buy Dividends | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 49.67 | USD | 2,301 | 15,323,704 |
| 14-May-26 | 12-May-26 | Transfer From | Julie Brown held the position of Chief Finance Officer at the time of this trade.Julie Brown | 0.00 | 7 | 44,492 | |
| 14-May-26 | 12-May-26 | Buy | Julie Brown held the position of Chief Finance Officer at the time of this trade.Julie Brown | 1,865.59 | GBX | 7 | 44,492 |
| 29-Apr-26 | 29-Apr-26 | Buy | Wendy Becker held the position of Non-Executive Director at the time of this trade.Wendy Becker | 1,962.91 | GBX | 4,000 | 21,250 |
At GSK, we unite science, technology and talent to get ahead of disease together